A detailed history of Coldstream Capital Management Inc transactions in Baxter International Inc stock. As of the latest transaction made, Coldstream Capital Management Inc holds 6,648 shares of BAX stock, worth $218,386. This represents 0.01% of its overall portfolio holdings.

Number of Shares
6,648
Previous 6,780 1.95%
Holding current value
$218,386
Previous $262,000 8.4%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$37.88 - $43.77 $5,000 - $5,777
-132 Reduced 1.95%
6,648 $284,000
Q4 2023

Feb 09, 2024

SELL
$31.71 - $38.95 $19,818 - $24,343
-625 Reduced 8.44%
6,780 $262,000
Q3 2023

Nov 02, 2023

SELL
$37.32 - $49.29 $140,061 - $184,985
-3,753 Reduced 33.64%
7,405 $279,000
Q2 2023

Aug 03, 2023

BUY
$39.98 - $47.68 $119,260 - $142,229
2,983 Added 36.49%
11,158 $508,000
Q1 2023

May 15, 2023

BUY
$37.58 - $52.57 $307,216 - $429,759
8,175 New
8,175 $331,000
Q2 2022

Aug 08, 2022

SELL
$63.83 - $80.0 $273,256 - $342,480
-4,281 Closed
0 $0
Q2 2022

Aug 08, 2022

BUY
$63.83 - $80.0 $245,936 - $308,240
3,853 New
3,853 $248,000
Q1 2022

May 11, 2022

SELL
$76.85 - $89.45 $22,286 - $25,940
-290 Reduced 6.34%
4,281 $332,000
Q4 2021

Feb 11, 2022

BUY
$74.57 - $87.19 $152,719 - $178,565
2,048 Added 81.17%
4,571 $392,000
Q3 2021

Nov 12, 2021

BUY
$73.77 - $83.61 $186,121 - $210,948
2,523 New
2,523 $203,000
Q1 2021

Jun 16, 2021

SELL
$76.38 - $86.03 $203,323 - $229,011
-2,662 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$75.39 - $82.36 $200,688 - $219,242
2,662 New
2,662 $214,000
Q3 2020

Nov 16, 2020

SELL
$78.33 - $90.73 $192,143 - $222,560
-2,453 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$78.66 - $94.14 $192,952 - $230,925
2,453 New
2,453 $211,000

Others Institutions Holding BAX

About BAXTER INTERNATIONAL INC


  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.6B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track This Portfolio

Track Coldstream Capital Management Inc Portfolio

Follow Coldstream Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.